Magnetocardiography in the diagnosis of suspected ANOCA: a case series - Report - MDSpire

Magnetocardiography in the diagnosis of suspected ANOCA: a case series

  • By

  • Xiaoyan Xue

  • Jiandong Zhang

  • Yuheng Zhou

  • Lei Cheng

  • Yihao Zhu

  • Jiaqi Liang

  • Kangqi Tian

  • Dong Xu

  • Shuting Xiang

  • Qian Li

  • Jun Xiao

  • Yu Ma

  • Xu Zhang

  • Min Xiang

  • June 19, 2026

  • 0 min

Share

Clinical Report: Utilizing Magnetocardiography for Diagnosing Suspected ANOCA

Overview

This case series analysis highlights the use of magnetocardiography (MCG) in diagnosing patients with angina pectoris and non-obstructive coronary artery disease (ANOCA).

Background

Patients with angina pectoris and non-obstructive coronary artery disease (ANOCA) often present with symptoms that mimic acute coronary syndrome (ACS), complicating diagnosis. A structured diagnostic approach is essential to identify underlying coronary functional abnormalities, such as coronary microvascular dysfunction (CMD).

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • MCG can distinguish mild myocardial ischemia in patients with suspected ANOCA.
  • Ischemic features on MCG waveforms were prominent even when ECG did not indicate ischemia.
  • Prior investigations have not systematically characterized specific MCG waveform patterns in the context of ANOCA or CMD.
  • MCG's application in cardiology is gaining attention for evaluating acute chest pain.

Clinical Implications

The findings suggest that MCG could serve as a valuable tool in the diagnostic evaluation of patients with suspected ANOCA, particularly when traditional methods are inconclusive. Incorporating MCG into clinical practice may enhance the identification of subtle ischemic changes.

Conclusion

This study describes the potential role of magnetocardiography in diagnosing ANOCA.

Related Resources & Content

  1. Clinical Research in Cardiology, 2025 -- Cardiac Magnetic Resonance Imaging-Based Quantitative Perfusion Analysis Identifies Myocardial Perfusion Deficits in Angina Patients with Non-Obstructive Coronary Artery Disease
  2. Clinical Research in Cardiology, 2020 -- Evaluating the Diagnostic Utility of Cardiovascular Magnetic Resonance Versus Endomyocardial Biopsy in Cardiac Amyloidosis: A Multi-Center Analysis
  3. European Radiology, 2023 -- Efficacy of a Brief Non-Contrast Cardiac Magnetic Resonance Imaging Protocol in MINOCA Cases
  4. Clinical Research in Cardiology, 2020 -- Evaluating the Novel CMR Metric 'Myocardial Transit Time' (MyoTT) for Identifying Microvascular Alterations in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
  5. 2024 ESC Guidelines for the management of chronic coronary syndromes | European Heart Journal | Oxford Academic
  6. Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes - ScienceDirect
  7. Frontiers | Effectiveness of magnetocardiography as a non-invasive tool for functional assessment of myocardial ischemia in patients with stable coronary artery disease
  8. 2024 ESC Guidelines for the management of chronic coronary syndromes | European Heart Journal | Oxford Academic
  9. Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes - ScienceDirect
  10. Frontiers | Effectiveness of magnetocardiography as a non-invasive tool for functional assessment of myocardial ischemia in patients with stable coronary artery disease

Original Source(s)

Magnetocardiography in the diagnosis of suspected ANOCA: a case series

  • by Xiaoyan Xue, Jiandong Zhang, Yuheng Zhou, Lei Cheng, Yihao Zhu, Jiaqi Liang, Kangqi Tian, Dong Xu, Shuting Xiang, Qian Li, Jun Xiao, Yu Ma, Xu Zhang, Min Xiang

  • June 19, 2026

Related Content

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

Case Study: An Emerging Etiology for ST-Segment Elevation in Lead aVR

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients